We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
-1.53%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.26B
AUM Growth
-$105M
Cap. Flow
-$52.6M
Cap. Flow %
-4.16%
Top 10 Hldgs %
60.92%
Holding
343
New
11
Increased
61
Reduced
233
Closed
34

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$51.8M
2
BEKE icon
KE Holdings
BEKE
+$31M
3
TSM icon
TSMC
TSM
+$10.9M
4
BZ icon
Kanzhun
BZ
+$6.35M
5
IQ icon
iQIYI
IQ
+$4.37M

Top Sells

Rank Stock Value
1
TME icon
Tencent Music
TME
+$39.2M
2
TCOM icon
Trip.com Group
TCOM
+$19.3M
3
MRVL icon
Marvell Technology
MRVL
+$12M
4
WB icon
Weibo
WB
+$7.99M
5
JOYY
JOYY Inc
JOYY
+$7.61M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 37.28%
2 Technology 32.43%
3 Communication Services 9.6%
4 Healthcare 8.37%
5 Real Estate 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNP icon
276
Union Pacific
UNP
$183B
$209K 0.02%
1,019
-121
-11% -$24.1K
ALLO icon
277
Allogene Therapeutics
ALLO
$601M
$204K 0.02%
41,061
+2,624
+7% +$14.2K
EW icon
278
Edwards Lifesciences
EW
$47.6B
$201K 0.02%
2,126
-323
-13% -$28.1K
BA icon
279
Boeing
BA
$165B
$200K 0.02%
945
-103
-10% -$21.4K
GE icon
280
GE Aerospace
GE
$367B
$200K 0.02%
+2,279
New +$185K
VRSN icon
281
VeriSign
VRSN
$25.3B
$200K 0.02%
886
-103
-10% -$22.7K
MCRB icon
282
Seres Therapeutics
MCRB
$48M
$199K 0.02%
2,079
+1,400
+206% +$152K
T icon
283
AT&T
T
$165B
$190K 0.02%
11,939
-1,338
-10% -$22.8K
DAWN
284
DELISTED
Day One Biopharmaceuticals
DAWN
$187K 0.01%
15,641
+4,774
+44% +$62.4K
SCLX icon
285
Scilex Holding
SCLX
$48.1M
$175K 0.01%
898
– –
DCPH
286
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$175K 0.01%
12,429
-859
-6% -$12.3K
CDNA icon
287
CareDx
CDNA
$1.92B
$157K 0.01%
18,437
-4,685
-20% -$39.1K
CDMO
288
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$154K 0.01%
10,990
+953
+9% +$16.2K
AVXL icon
289
Anavex Life Sciences
AVXL
$222M
$153K 0.01%
18,853
-7,561
-29% -$64.8K
ADMA icon
290
ADMA Biologics
ADMA
$1.92B
$142K 0.01%
38,613
-17,090
-31% -$63.3K
SIRI icon
291
SiriusXM
SIRI
$10B
$135K 0.01%
2,973
-492
-14% -$18.6K
COGT icon
292
Cogent Biosciences
COGT
$6.79B
$131K 0.01%
11,088
-2,661
-19% -$30.5K
RXRX icon
293
Recursion Pharmaceuticals
RXRX
$1.57B
$129K 0.01%
17,229
-4,188
-20% -$29.3K
TSVT
294
DELISTED
2seventy bio
TSVT
$126K 0.01%
12,420
-181
-1% -$1.92K
AGEN
295
Agenus
AGEN
$249M
$124K 0.01%
3,866
-2,444
-39% -$78.2K
QURE icon
296
uniQure
QURE
$2.68B
$122K 0.01%
10,653
-1,593
-13% -$30.2K
VTRS icon
297
Viatris
VTRS
$20.1B
$120K 0.01%
12,016
+130
+1% +$1.24K
ALDX icon
298
Aldeyra Therapeutics
ALDX
$91.7M
$114K 0.01%
+13,612
New +$134K
KURA icon
299
Kura Oncology
KURA
$922M
$112K 0.01%
10,628
-4,960
-32% -$58.7K
SANA icon
300
Sana Biotechnology
SANA
$885M
$108K 0.01%
18,054
-5,126
-22% -$29.5K
10 11
12
13 14

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q2 2023 Portfolio in Review

As of Q2 2023, E Fund Management held 343 positions worth $1.26B, down 7.7% from $1.37B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

E Fund Management withdrew a net $52.6M in Q2 2023, closing 34 positions and reducing 233 holdings. Its most notable exit was Trip.com Group, an estimated $19.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, up from 36% a quarter earlier, followed by Technology and Communication Services.

Against the trend, E Fund Management opened a new position in Datadog worth $881K.

  • E Fund Management's largest Q2 2023 buy was Datadog: 8,960 shares worth $881K.
  • E Fund Management added most to Pinduoduo in Q2 2023, an estimated $51.8M increase.
  • E Fund Management's biggest Q2 2023 reduction was Tencent Music, cutting an estimated $39.2M.
  • E Fund Management fully exited Trip.com Group in Q2 2023, selling an estimated $19.3M.
  • E Fund Management's ten largest holdings make up 61% of its $1.26B portfolio in Q2 2023.
  • E Fund Management opened 11 new positions and closed 34 in Q2 2023.
  • E Fund Management's portfolio value fell 7.7% quarter-over-quarter to $1.26B.

Based on E Fund Management's 13F filing for Q2 2023, filed 11 Aug 2023.